OAR 333-023-0815
Notification to Patients

Using language provided by the Authority, a pharmacy shall notify each patient receiving a controlled substance about the Prescription Drug Monitoring Program before or when the controlled substance is dispensed to the patient. The notification shall include that the prescription will be entered into the system.

Source: Rule 333-023-0815 — Notification to Patients, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=333-023-0815.

Last Updated

Jun. 8, 2021

Rule 333-023-0815’s source at or​.us